NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

621. Assessing user fees under the biosimilar user fee amendments of 2017

623. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components

625. Use of electronic health record data in clinical investigations

627. Clarification of orphan designation of drugs and biologics for pediatric subpopulations of common diseases

630. Dissolution testing and acceptance criteria for immediate-release solid oral dosage form drug products containing high solubility drug substances